ReleaseWire Connect

As per the new research report by RNCOS, “Brain Signal Analysis Software Market Outlook to 2017”, brain signal analysis software represents a niche product category that caters to a very specific segment of the global medical device industry. Our study reveals that the market for brain signal analysis software is expected to grow at a double-digit growth rate of 15% during 2012-2017; higher than the traditional medical device market.

Currently, the Americas is the largest market in terms of miRNA based research. Within the Americas, the US is the chief geography wherein majority of the research associated with miRNA diagnostics/therapeutics application is being carried on. The miRNA market in the Americas is likely to reach US$ 594 Million by 2018. The respective market is anticipated to grow at an impressive CAGR of around 22% over the 6 year period spanning from 2012 to 2018.

US healthcare IT market is going through a tremendous growth phase as country’s government is providing requisite support to the industry by providing huge incentives and formulating various regulations. Moreover, there has been introduction of many programs which would provide significant investments in healthcare IT technical assistance and resources to assist providers with adopting, implementing, and optimizing the use of customizable health IT tools and thus enhancing the adoption rate.

Partnerships are evolving rapidly and seem to drive the biosimilar market globally. The big pharmaceutical giants have been aggressively involved in certain agreements for early development of biosimilars soon as and when the product patent expire. Moreover, the companies have been expanding their reach and increasing their market share by the way of collaborations and agreements. For instance, Baxter International and Coherus Biosciences have entered into an exclusive collaboration to develop and commercialize a biosimilar to etanercept for Europe, Canada, Brazil. Besides, Government across the globe have been trying to explore more options for healthcare cost containment.

The major market for sports footwear lies in tier two and tier three cities in China. The consumers in these regions have enormous purchasing potential and have variety of options to choose between domestic and international brands. Over the past few years, the domestic and international athletic footwear manufacturers have expanded their sales network rapidly in tier two and three cities in China.

Saudi Arabia is one of the largest countries in terms of population and gross national product. The Kingdom’s national economy has grown exponentially over the last ten years, due to which the country has initiated massive infrastructural development projects which includes construction of roads, bridges and railways, etc. According to a new report by RNCOS “Saudi Arabia Steel Industry Outlook 2018”, in lieu of the above, the demand for steel has risen in the Kingdom over the past few years, propelling an equivalent increase in the consumption and production of steel.

Increasing urbanization and rapidly changing lifestyle is contributing to the surge in prevalence of Cardiovascular and Coronary Heart Diseases. This incidence is expected to touch 61.5 Million by 2015. Apart from Cardiovascular Diseases, other lifestyle related disorders such as Obesity, Diabetes and Cancer are also on a rise. This rise in disease incidence will be a major influence in driving the Indian Diagnostic Market.

Continuously increasing prevalence of diabetes led to growing demand of diabetes drugs. A lot of pharmaceutical players have been investing into research and development for insulin drug therapies. They have been investing in diabetic product portfolio and continuously making efforts to increase their market shares. Even the government organizations have been involved in various patient programs for introduction of technologically advanced delivery devices. Such type of awareness programs at government level or by pharmaceutical players increase the revenue from diabetes drugs across the country.

As per the new research report by RNCOS, “Emerging NIPT Market in Asia Pacific”, the market for non-invasive prenatal testing in China is expanding at a rapid rate. This growth can be attributed to several factors, foremost of all being its high acceptance amongst high-risk pregnant women. Currently, BGI Health, a subsidiary of BGI China and Berry Genomics are the only two players in the highly lucrative market of China NIPT. Both the firms started offering their NIPT services in late 2011.

The corrugated box market in India is predicted to witness a sizeable growth in coming years, owing to its escalating demand by various industries. Eyeing this remarkable growth opportunity, various international players are now entering the country’s corrugated box industry to garner profits. Many Indian corrugated machinery manufacturers are entering into alliances with Chinese, Taiwanese & European manufacturers for the manufacture of these machineries. Therefore, these overseas alliances are set to bring about technological up-gradations and significant growth in the Indian corrugated box industry. Considering the above factors, the Indian corrugated box industry is projected to grow at a CAGR of around 15% during the forecast period 2013-2017.